Home trial
 

Keywords :   


Tag: trial

Nissan and Enel to launch major V2G trial in the UK; LEAF and e-NV200

2016-05-10 21:56:12| Green Car Congress

Tags: uk major trial launch

 

Volvo Cars to launch UKs largest autonomous driving trial

2016-04-27 12:56:12| Green Car Congress

Tags: cars trial largest driving

 
 

Swisscom LTE-Advanced Pro trial hits 1 Gbps

2016-04-21 02:00:00| Total Telecom industry news

Swiss incumbent plans commercial launch early in 2017.

Tags: pro trial hits swisscom

 

Second Baby Powder Ovarian Cancer Trial Opens in Missouri

2016-04-16 05:40:56| Food - Topix.net

Attorneys presented opening arguments in a jury trial to determine whether the talc in Johnson & Johnson's baby powder caused a 62-year-old woman's ovarian cancer. According to news reports, the plaintiff, Gloria Ristesund, was diagnosed with ovarian cancer in 2011 and had her uterus removed after decades of using Johnson's Baby Powder in her genital area.

Tags: baby trial cancer missouri

 

Mercks ZEPATIER (Elbasvir and Grazoprevir) Showed Superiority on Efficacy and Safety Endpoints Compared to Sofosbuvir Plus Peginterferon and Ribavirin Treatment Regimen in Phase 3 Trial

2016-04-14 07:00:00| Merck.com - Corporate News

Dateline City: KENILWORTH, N.J. Results From C-EDGE Head-to-Head Study in Patients with Chronic Hepatitis C Genotypes 1 or 4 Infection Presented at The International Liver Congress 2016 KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the presentation of results from C-EDGE Head-to-Head, the companys comparative, Phase 3, open-label clinical trial evaluating the efficacy and safety of ZEPATIER (elbasvir and grazoprevir) 50mg/100mg tablets versus a regimen of sofosbuvir 400mg tablets plus peginterferon and ribavirin (pegIFN/RBV) in treatment-nave and pegIFN/RBV treatment-experienced patients with chronic hepatitis C (HCV) genotype (GT) 1 or GT4 infect Language: English Contact: MerckMedia:Pamela Eisele, 267-305-3558Sarra Herzog, 201-669-6570orInvestors:Teri Loxam, 908-740-1986Amy Klug, 908-740-1898 Ticker Slug: Ticker: MRK Exchange: NYSE read more

Tags: in safety treatment trial

 

Sites : [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] next »